c-Jun

c-Jun, a basic leucine zipper transcription factor, regulates gene expression in response to multiple extracellular signals^[1]. It is a central component of the activator protein-1 (AP-1) complex, mediating cellular proliferation, differentiation, and stress responses^[2][3]. Mechanistically, c-Jun is primarily activated by phosphorylation through the c-Jun N-terminal kinase (JNK) pathway, linking stress signals to transcriptional outputs^[3][4]. Isoform-specific functions of JNK1, JNK2, and JNK3 modulate c-Jun activity in tissue- and cell-specific contexts, influencing apoptosis, inflammation, and neuroplasticity^[1][5][6]. In disease models, c-Jun contributes to pathological angiogenesis, rheumatoid arthritis, and neurodegeneration, where its inhibition reduces endothelial proliferation, metalloproteinase expression, and neuronal apoptosis^{[7][8][9][10][11][12]}. Compared with related Jun-family members, c-Jun exhibits distinct phosphorylation patterns and transcriptional targets, enabling isoform-specific experimental interventions^[6][13]. Pharmacological inhibitors targeting JNK or c-Jun itself, such as SP600125 or DNAzymes, demonstrate utility in blocking pro-apoptotic signaling, reducing inflammation, and modulating angiogenic pathways, supporting their research and therapeutic application^{[7][8][10][12]}. In cancer and viral models, c-Jun interacts with oncogenic pathways, including Bcl-2/Bcl-xL upregulation and FGF-2-mediated proliferation, highlighting its role in cell survival and transcriptional regulation^[2][14]. Collectively, c-Jun integrates stress, mitogenic, and inflammatory signals, serving as a critical target for isoform-specific modulation in experimental and disease contexts^[1][3][6][7].